Announcements Trials
Browse Landscape

Phase

Phase 2 32Phase 3 23Phase 1 9Phase 4 2Phase 1/2 2Phase NA 1Phase 2/3 1

Status

Completed 17Terminated 5Unknown 4Withdrawn 3Recruiting 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Polycystic Ovary Syndrome 1Infertility 1Breast Neoplasms 1

Interventions

Human Papillomavirus Recombinant Vaccine nonavalent 5Prednisone 3Dexamethasone 3Cisplatin 3Atorvastatin 3olaparib 2lorlatinib 2human papillomavirus vaccine, L1 type 16, 18 2enzalutamide 2adacel 2Tobacco Use Cessation Devices 2Tetanus Toxoid 2Papillomavirus Vaccines 2Letrozole 2Diphtheria-Tetanus-acellular Pertussis Vaccines 2Diphtheria Toxoid 2Denosumab 2Carboplatin 2Anesthesia, Epidural 2Abiraterone Acetate 2xiapex 1venetoclax 1tirbanibulin 1tenofovir alafenamide 1sofosbuvir-velpatasvir drug combination 1ruxolitinib 1ribociclib 1radium Ra 223 dichloride 1pembrolizumab 1pasireotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Active not recruiting × Letrozole × Clear all
NCT05161195 2026-04-02

Roll-over Study to Allow Continued Access to Ribociclib

Novartis

Phase 4 Active not recruiting
134 enrolled
Breast

Breast Neoplasms

NCT05206448 2025-04-15

CLC II

University of Iowa

Phase 4 Active not recruiting
190 enrolled 15 charts

Infertility, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡